Travere Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TVTX)

CUSIP: 89422G107

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
89,403,587
Total 13F shares
84,151,882
Share change
+11,264,897
Total reported value
$1,892,538,812
Put/Call ratio
128%
Price per share
$22.49
Number of holders
171
Value change
+$263,849,900
Number of buys
118
Number of sells
46

Quarterly Holders Quick Answers

What is CUSIP 89422G107?
CUSIP 89422G107 identifies TVTX - Travere Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Travere Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TVTX) as of Q1 2023

As of 31 Mar 2023, Travere Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TVTX) was held by 171 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 84,151,882 shares. The largest 10 holders included ARMISTICE CAPITAL, LLC, JANUS HENDERSON GROUP PLC, Deep Track Capital, LP, BlackRock Inc., STATE STREET CORP, ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, MACQUARIE GROUP LTD, RENAISSANCE TECHNOLOGIES LLC, and ORBIMED ADVISORS LLC. This page lists 171 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.